產(chǎn)品屬性：
產(chǎn)品名稱(chēng) | STAT3-IN-1 |
規(guī)格 | 5mg、10mg、50mg、100mg |
貨號(hào) | EY-01Y12303 |
Cas No.: 2059952-75-7
別名: N/A
化學(xué)名: N/A
分子式: C28H29NO6
分子量: 475.53
溶解度: DMSO: 125 mg/mL (262.86 mM)
儲(chǔ)存條件: Store at -20°C
General tipsFor obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.
Shipping ConditionEvaluation sample solution : ship with blue ice
All other available size: ship with RT , or blue ice upon request
產(chǎn)品描述：
STAT3-IN-1 (compound 7d) is an excellent, selective and orally active STAT3 inhibitor, with IC50 values of 1.82 μM and 2.14 μM in HT29 and MDA-MB 231 cells, respectively. STAT3-IN-1 (compound 7d) induces tumor apoptosis[1].IC50: 1.82 μM (STAT3 in HT29 cells), 2.14 μM (STAT3 in MDA-MB 231 cells)[1].STAT3-IN-1 (compound 7d: 0-10 μM, 48 h) inhibits the STAT3 acetylation at lysine 685 and affected its specific genes expressions[1].STAT3-IN-1 (compound 7d: 0-10 μM, 48 h) induces tumor cells apoptosis in MDA-MB-231 cells[1].Apoptosis Analysis[1] Cell Line:MDA-MB-231 cell lines.STAT3-IN-1 (compound 7d: 10, 20 mg/kg, two weeks) arrests tumor growth with low toxicity in mouse-xenograft model[1].Animal Model:Mouse-xenograft model bearing inoculation of mice breast cancer 4T1 cells[1].[1]. Li S, et al. Discovery of oral-available resveratrol-caffeic acid based hybrids inhibiting acetylated and phosphorylated STAT3 protein. Eur J Med Chem. 2016 Nov 29;124:1006-1018.
特別提醒公司產(chǎn)品僅供科研使用
